{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:55:37Z","timestamp":1793922937564,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.amjms.2016.08.015","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T21:00:57Z","timestamp":1472158857000},"page":"517-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Effect of Dapagliflozin Treatment on Fluid and Electrolyte Balance in Diabetic Rats"],"prefix":"10.1016","volume":"352","author":[{"given":"Ling","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"LaRocque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhan","family":"Efe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff M.","family":"Sands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet D.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.amjms.2016.08.015_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00232-001-0036-y","article-title":"Changes in sodium or glucose filtration rate modulate expression of glucose transporters in renal proximal tubular cells of rat","volume":"182","author":"Vestri","year":"2001","journal-title":"J Membr Biol"},{"issue":"7","key":"10.1016\/j.amjms.2016.08.015_bib2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrd3180","article-title":"SGLT2 inhibition\u2014a novel strategy for diabetes treatment","volume":"9","author":"Chao","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1016\/j.amjms.2016.08.015_bib3","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.2337\/dc15-0642","article-title":"Sodium-glucose cotransporter inhibitors: effects on renal and intestinal glucose transport from bench to bedside","volume":"38","author":"Mudaliar","year":"2015","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.amjms.2016.08.015_bib4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jdiacomp.2014.04.010","article-title":"Beneficial effects of phlorizin on diabetic nephropathy in diabetic db\/db mice","volume":"28","author":"Pei","year":"2014","journal-title":"J Diabetes Complications"},{"issue":"5","key":"10.1016\/j.amjms.2016.08.015_bib5","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1007\/s11033-011-1328-7","article-title":"Phloridzin reduces blood glucose levels and improves lipids metabolism in streptozotocin-induced diabetic rats","volume":"39","author":"Najafian","year":"2012","journal-title":"Mol Biol Rep"},{"issue":"1","key":"10.1016\/j.amjms.2016.08.015_bib6","doi-asserted-by":"crossref","first-page":"e010252","DOI":"10.1136\/bmjopen-2015-010252","article-title":"Comparative effectiveness of sodium-glucose co-transporter 2 inhibitors for controlling hyperglycaemia in patients with type 2 diabetes: protocol for a systematic review and network meta-analysis","volume":"6","author":"Chen","year":"2016","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.amjms.2016.08.015_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/dom.12273","article-title":"Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone","volume":"16","author":"Forst","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.amjms.2016.08.015_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.lfs.2016.01.042","article-title":"Effect of ipragliflozin, an SGLT2 inhibitor, on progression of diabetic microvascular complications in spontaneously diabetic Torii fatty rats","volume":"147","author":"Takakura","year":"2016","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.amjms.2016.08.015_bib9","doi-asserted-by":"crossref","first-page":"F317","DOI":"10.1152\/ajprenal.00145.2014","article-title":"The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob\/ob type 2 diabetic mice with and without hypertension","volume":"307","author":"Gembardt","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"10.1016\/j.amjms.2016.08.015_bib10","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2337\/dc14-0315","article-title":"Dapagliflozin\u2019s effects on glycemia and cardiovascular risk factors in high-risk patients with type 2 diabetes: A 24-week, multicenter, randomized, double-blind, placebo-controlled study with a 28-week extension","volume":"38","author":"Cefalu","year":"2015","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.amjms.2016.08.015_bib11","doi-asserted-by":"crossref","first-page":"F303","DOI":"10.1152\/ajprenal.00438.2002","article-title":"Changes in renal medullary transport proteins during uncontrolled diabetes mellitus in rats","volume":"285","author":"Kim","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.amjms.2016.08.015_bib12","first-page":"F949","article-title":"Glucocorticoids mediate a decrease in the AVP-regulated urea transporter in diabetic rat inner medulla","volume":"273","author":"Klein","year":"1997","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.amjms.2016.08.015_bib13","first-page":"F96","article-title":"Vasopressin increases Na-K-2Cl cotransporter expression in thick ascending limb of Henle\u2019s loop","volume":"276","author":"Kim","year":"1999","journal-title":"Am J Physiol"},{"issue":"6","key":"10.1016\/j.amjms.2016.08.015_bib14","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1046\/j.1523-1755.2001.00048.x","article-title":"Expression of salt and urea transporters in rat kidney during cisplatin-induced polyuria","volume":"60","author":"Ecelbarger","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjms.2016.08.015_bib15","doi-asserted-by":"crossref","first-page":"11663","DOI":"10.1073\/pnas.90.24.11663","article-title":"Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney","volume":"90","author":"Nielsen","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.amjms.2016.08.015_bib16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1046\/j.1523-1755.2000.00216.x","article-title":"Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria","volume":"58","author":"Kishore","year":"2000","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.amjms.2016.08.015_bib17","doi-asserted-by":"crossref","first-page":"e0141714","DOI":"10.1371\/journal.pone.0141714","article-title":"NSAIDs alter phosphorylated forms of AQP2 in the inner medullary tip","volume":"10","author":"Ren","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.amjms.2016.08.015_bib18","first-page":"72","article-title":"Blood volume in the rat","volume":"26","author":"Lee","year":"1985","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.amjms.2016.08.015_bib19","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2337\/db07-1472","article-title":"Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats","volume":"57","author":"Han","year":"2008","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.amjms.2016.08.015_bib20","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1152\/ajpregu.00357.2011","article-title":"Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat","volume":"302","author":"Thomson","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"10.1016\/j.amjms.2016.08.015_bib21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1681\/ASN.2010030246","article-title":"SGLT2 mediates glucose reabsorption in the early proximal tubule","volume":"22","author":"Vallon","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.amjms.2016.08.015_bib22","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/ki.2014.246","article-title":"Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes","volume":"86","author":"Cherney","year":"2014","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.amjms.2016.08.015_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/MNH.0000000000000152","article-title":"Sodium-glucose cotransport","volume":"24","author":"Poulsen","year":"2015","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1016\/j.amjms.2016.08.015_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1517\/13543784.2013.740009","article-title":"Dapagliflozin: a review on efficacy, clinical effectiveness and safety","volume":"22","author":"Paisley","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"10.1016\/j.amjms.2016.08.015_bib25","doi-asserted-by":"crossref","first-page":"F188","DOI":"10.1152\/ajprenal.00200.2004","article-title":"Urea may regulate urea transporter protein abundance during osmotic diuresis","volume":"288","author":"Kim","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1016\/j.amjms.2016.08.015_bib26","doi-asserted-by":"crossref","first-page":"F188","DOI":"10.1152\/ajprenal.00518.2013","article-title":"Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia","volume":"306","author":"Rieg","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"10.1016\/j.amjms.2016.08.015_bib27","doi-asserted-by":"crossref","first-page":"F1098","DOI":"10.1152\/ajprenal.00505.2014","article-title":"A mathematical model of the rat nephron: glucose transport","volume":"308","author":"Weinstein","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"issue":"Pt 2","key":"10.1016\/j.amjms.2016.08.015_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1469-7793.2000.00251.x","article-title":"Urea transport by cotransporters","volume":"528","author":"Leung","year":"2000","journal-title":"J Physiol"},{"key":"10.1016\/j.amjms.2016.08.015_bib29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fphys.2012.00176","article-title":"The role of nitric oxide in the dysregulation of the urine concentration mechanism in diabetes mellitus","volume":"3","author":"Cipriani","year":"2012","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.amjms.2016.08.015_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/toxsci\/kfp134","article-title":"Effects of nitric oxide and antioxidants on advanced glycation end products-induced hypertrophic growth in human renal tubular cells","volume":"111","author":"Huang","year":"2009","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1016\/j.amjms.2016.08.015_bib31","doi-asserted-by":"crossref","first-page":"F103","DOI":"10.1152\/ajprenal.00385.2012","article-title":"Urine concentration in the diabetic mouse requires both urea and water transporters","volume":"304","author":"Ilori","year":"2013","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962916304438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962916304438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T20:56:14Z","timestamp":1536440174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962916304438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0002962916304438"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2016.08.015","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Dapagliflozin Treatment on Fluid and Electrolyte Balance in Diabetic Rats","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2016.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Southern Society for Clinical Investigation. Published by All rights reserved.","name":"copyright","label":"Copyright"}]}}